瘤性PI3K脂类激酶变体在膜及其神秘口袋中的机制
Hyunbum Jang1,2, Bengi Ruken Yavuz2, Mingzhen Zhang1
1Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, U.S.A.
bioRxiv : the preprint server for biology
|July 16, 2025
概括
癌症是由至少两种突变引起的. 将癌症热点突变与较弱的突变相结合,会产生分级的效应谱,影响蛋白质行为和药物向.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物物理学的生物物理.
背景情况:
- 癌症的发展需要至少两种突变.
- 易患癌症的等位基因经常存在热点突变.
- PI3Kα变种可以呈现与瘤,良性瘤或神经发育障碍相关的突变.
研究的目的:
- 为了研究组合突变对PI3Kα变异行为的影响.
- 为了探索"一两拳"癌症出现的假设.
- 确定PI3Kα变体的潜在药物标和治疗策略.
主要方法:
- 在PI3Kα中对相同基因的双重突变进行统计分析.
- 对PI3Kα变体的原子分子动力学 (MD) 模拟.
- 鉴定特定突变的密码口袋.
主要成果:
- 组合热点和弱/中度突变创造了一个分级的临床表型谱.
- 双重突变比单一突变更容易将PI3Kα形态组合转移到活性形式.
- 鉴定出了特定突变的加密口袋,提供了潜在的药物向网站.
结论:
- "一两拳"假说得到了PI3Kα突变数据的支持.
- 与全性药物相结合的形状选择策略可以有效地治疗PI3Kα变体.
- 在双重突变中发现了潜在的共存的囊,指导了未来的药物开发.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Phosphoinositides and PIPs
8.7K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
IP3/DAG Signaling Pathway
12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K
Lipids as Anchors
5.9K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
5.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


